OKYO Pharma (OKYO) 10% Owner Gabriele M. Cerrone Receives Award

What Happened
Gabriele M. Cerrone, listed as a 10% owner of OKYO Pharma Ltd (OKYO), was granted 22,500 shares on July 21, 2026. The award is reported at an acquisition price of $1.45 per share, for a total reported value of $32,625. This was an award/grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-21; filing date: 2026-07-23 (appears timely within typical Form 4 reporting window).
• Shares granted: 22,500 at $1.45/share; total value $32,625.
• Transaction type/code: Award/Grant (A) — acquisition via award.
• Shares owned after transaction: not specified in the provided filing details.
• No footnotes, 10b5-1 plan, or tax-withholding details were disclosed in the summary data provided.

Context

• An award/grant is an acquisition but is usually compensation-related; it differs from an open-market purchase and does not necessarily signal the insider’s view on share price.
• As a 10% owner, Cerrone is a large stakeholder (insider) rather than necessarily an executive; such transactions can reflect ownership arrangements or compensation rather than routine trading decisions.